Frontiers Case report: Short-term eculizumab use in atypical HUS
Descrição
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies - ScienceDirect
Frontiers Recommendations for the individualised management of atypical hemolytic uremic syndrome in adults
COVID-19 Triggers Relapse in Woman With aHUS: Case Study
PDF) Hemolytic uremic syndrome in the setting of COVID-19 successfully treated with complement inhibition therapy: An instructive case report of a previously healthy toddler and review of literature
Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era
PDF) Long-term remission of atypical HUS with anti-factor H antibodies after cyclophosphamide pulses
atypical hemolytic uremic syndrome - List of Frontiers' open access articles
Pregnancy associated atypical hemolytic uremic syndrome presenting with preeclampsia with HELLP syndrome and following treatment with Eculizumab
Preemptive plasma therapy prevents atypical hemolytic uremic syndrome relapse in kidney transplant recipients - ScienceDirect
de
por adulto (o preço varia de acordo com o tamanho do grupo)
